RISK OF INCIDENT HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B (CHB) VIRUS-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS ENTECAVIR (ETV): A US ADMINISTRATIVE CLAIMS ANALYSIS Kim, R., Telep, L., Lu, M., Ramroth, H., Flaherty, J., Gaggar, A., Chokkalingam, A., Chan, C., Gordon, S. BMJ PUBLISHING GROUP. 2020: A73

View details for DOI 10.1136/gutjnl-2020-IDDF.140

View details for Web of Science ID 000617041900141